Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 18, 2018 14:00 ET | Source: bioAffinity Technologies, Inc.

Mount Sinai Joins Test Validation Trial of bioAffinity’s CyPath® Lung

SAN ANTONIO, Sept. 18, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held biotech company, today announced that the Icahn School of Medicine at Mount Sinai (ISMMS) in New York, NY,...
January 05, 2018 09:00 ET | Source: bioAffinity Technologies, Inc.

bioAffinity Technologies to Present at Biotech Showcase™ Annual Conference

SAN ANTONIO, Texas, Jan. 05, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held cancer diagnostics company, today announced that it will present its proprietary technology to detect...
March 09, 2017 19:02 ET | Source: bioAffinity Technologies, Inc.

City of San Antonio Invests in bioAffinity Technologies

SAN ANTONIO, March 09, 2017 (GLOBE NEWSWIRE) -- The San Antonio City Council today authorized the San Antonio Economic Development Corporation (SAEDC) to invest in locally based bioAffinity...
November 15, 2016 09:00 ET | Source: bioAffinity Technologies, Inc.

bioAffinity Technologies Announces Award of Hong Kong Patent

SAN ANTONIO, Nov. 15, 2016 (GLOBE NEWSWIRE) -- bioAffinity Technologies announced that the government of the Hong Kong Special Administrative Region has awarded a Certificate of Grant of Standard...
July 13, 2016 08:00 ET | Source: bioAffinity Technologies, Inc.

bioAffinity Technologies and UT Health Science Center Collaborate to Optimize Cancer Diagnostics and Therapeutics

SAN ANTONIO, July 13, 2016 (GLOBE NEWSWIRE) -- bioAffinity Technologies today announced the renewal of its collaborative agreement with The University of Texas Health Science Center at San Antonio...
June 23, 2016 08:00 ET | Source: bioAffinity Technologies, Inc.

bioAffinity Technologies Forms Subsidiary to Focus on Targeted Cancer Drug Delivery

SAN ANTONIO, Texas, June 23, 2016 (GLOBE NEWSWIRE) -- bioAffinity Technologies today announced the formation of OncoSelect Therapeutics, LLC, a subsidiary company that will leverage bioAffinity’s...
April 12, 2016 09:00 ET | Source: bioAffinity Technologies, Inc.

bioAffinity Technologies Presents CyPath® Technology at International Lung Cancer Conference

SAN ANTONIO, April 12, 2016 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held cancer diagnostics company, will present its proprietary technology for the detection of early-stage lung...